Skip to main content
MAJI logo

Nextel Medical Corp. (MAJI) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0023 -$0.0001 (-4.17%)
P/E Ratio: 0.54| Vol: 750.0K|

P/E 0.54 means the share price is 0.54 times one year of earnings per share.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Nextel Medical Corp. (MAJI) trades at $0.0023. Marijuana Inc. distributes cannabis products within the United States. Formerly GRN Holding Corporation, the company rebranded in October 2024 and is based in Estero, Florida. Sector: Healthcare.

Price as of · Last analyzed: Mar 16, 2026
Marijuana Inc. distributes cannabis products within the United States. Formerly GRN Holding Corporation, the company rebranded in October 2024 and is based in Estero, Florida.

Analyst Coverage for MAJI: MAJI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • RLYB · Rallybio Corporation · 82 /100
  • ICCC · ImmuCell Corporation · 82 /100
  • ORMP · Oramed Pharmaceuticals Inc. · 72 /100

See all scored stocks →

Nextel Medical Corp. (MAJI) Healthcare & Pipeline Overview

CEODonald J. Steinberg
Employees2
HeadquartersEstero, US
IPO Year2012

Marijuana Inc. distributes cannabis products in the United States, operating within the specialty and generic drug manufacturing sector. Founded in 2010, the company focuses on distribution, facing competition and regulatory hurdles in the evolving cannabis market. It has a market capitalization of $0.00B.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for MAJI?

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Marijuana Inc. presents a speculative investment opportunity within the cannabis distribution sector. The company's small market capitalization ($0.00B) and negative P/E ratio (-12.70) indicate it is not currently profitable. Growth depends on navigating the evolving regulatory landscape of the cannabis industry and expanding its distribution network. Investors should carefully consider the risks associated with OTC-traded companies and the competitive pressures within the cannabis market. The company's future hinges on its ability to achieve profitability and scale its operations effectively.

Based on FMP financials and quantitative analysis

MAJI Key Highlights

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.

  • Negative P/E ratio of -12.70 suggests the company is currently not profitable.
  • Beta of -4.81 indicates high volatility and a negative correlation with the overall market.
  • The company operates in the evolving cannabis industry, which is subject to changing regulations and market dynamics.
  • The company changed its name from GRN Holding Corporation to Marijuana Inc. in October 2024, reflecting a strategic shift towards the cannabis market.

Who Are MAJI's Competitors?

MAJI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
RLYB Rallybio Corporation $15.26 -0.20% $85.5M 82 5-pillar
ICCC ImmuCell Corporation $11.25 -0.71% $102M 82 5-pillar
ORMP Oramed Pharmaceuticals Inc. $3.89 +0.52% $169M 72 5-pillar
CGEN Compugen Ltd. $1.88 -4.08% $178M 69 5-pillar
PLX Protalix BioTherapeutics, Inc. $3.06 +1.32% $258M 90 5-pillar
FENC Fennec Pharmaceuticals Inc. $13.33 -1.84% $471M 91 5-pillar
INDP Indaptus Therapeutics, Inc. $3.13 -4.86% $481M 60 5-pillar
ZVRA Zevra Therapeutics, Inc. $9.07 -2.26% $540M 91 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are MAJI's Key Strengths?

Established distribution network within the United States.

  • Focus on the growing cannabis market.
  • Experience in navigating the regulatory landscape.
  • Potential for brand development.

What Are MAJI's Weaknesses?

Small size and limited resources.

  • Negative profitability and low market capitalization.
  • High volatility and dependence on regulatory changes.
  • Limited product diversification.

What Are the Key Risks for MAJI?

Financial-distress signal — its Altman Z-Score of 1.18 sits in the distress zone (elevated bankruptcy risk).

  • Negative return on equity (-4.6%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • Intense competition from larger cannabis companies with greater resources.
  • Changing regulations and potential for increased restrictions on cannabis distribution.
  • Fluctuations in cannabis prices and demand, impacting profitability.
  • Difficulty accessing capital and financing due to the stigma associated with the cannabis industry.
  • Legal challenges and compliance costs associated with operating in a highly regulated industry.

What Are MAJI's Competitive Advantages?

  • Established distribution network within specific regions.
  • Potential brand recognition if branded products are developed.
  • Expertise in navigating the complex regulatory landscape of the cannabis industry.
  • Relationships with key retailers and suppliers in the cannabis market.

What Does MAJI Do?

Marijuana Inc., headquartered in Estero, Florida, operates as a distributor of cannabis products within the United States. The company was established in 2010 and initially functioned under the name GRN Holding Corporation. In October 2024, the company underwent a rebranding, officially changing its name to Marijuana Inc. This change reflects the company's strategic focus on the cannabis market. Marijuana Inc. navigates a complex regulatory landscape, typical of the cannabis industry, while focusing on distribution channels. The company's operations are concentrated within the United States, where it aims to capitalize on the increasing acceptance and legalization of cannabis products across various states. As a distributor, Marijuana Inc. plays a role in connecting cannabis producers with retailers and consumers, managing logistics, and ensuring compliance with local regulations. The company's small size, with only two employees, suggests a lean operational structure, possibly relying on outsourcing or partnerships for various functions. The company's success depends on its ability to adapt to changing market dynamics, regulatory changes, and competitive pressures within the cannabis industry.

What Products and Services Does MAJI Offer?

  • Distributes cannabis products within the United States.
  • Connects cannabis producers with retailers and consumers.
  • Manages logistics and supply chain for cannabis products.
  • Ensures compliance with local regulations regarding cannabis distribution.
  • Focuses on expanding its distribution network across various states.
  • Potentially develops its own branded cannabis products.
  • May explore strategic acquisitions within the cannabis industry.

How Does MAJI Make Money?

  • Generates revenue by distributing cannabis products to retailers and dispensaries.
  • Potentially earns revenue through the sale of branded cannabis products.
  • May generate revenue through licensing or franchising agreements.
  • Profitability depends on efficient supply chain management and regulatory compliance.

What Industry Does MAJI Operate In?

Marijuana Inc. operates within the rapidly evolving cannabis industry, which is characterized by increasing legalization and acceptance in various regions. The market is highly competitive, with numerous players vying for market share in cultivation, processing, distribution, and retail. The industry is subject to stringent regulations, which vary significantly by jurisdiction. Companies must navigate complex licensing requirements, quality control standards, and restrictions on marketing and sales. The overall market is experiencing substantial growth, driven by increasing consumer demand and expanding medical applications. However, companies like Marijuana Inc. face challenges related to competition, regulatory compliance, and access to capital.

Who Are MAJI's Key Customers?

  • Retail dispensaries selling cannabis products to consumers.
  • Medical cannabis patients seeking cannabis-based therapies.
  • Recreational cannabis users in states where it is legal.
  • Potentially, other businesses in the cannabis industry through B2B partnerships.
Model self-rating on this text: 69% (not a measure of the evidence) Updated: Mar 16, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage
F-Score 2/9

Financial Health

Nextel Medical Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 1.18 places it in the distress zone, a signal of elevated financial risk.

ROE -5%

Key Financial Metrics

Return on equity for Nextel Medical Corp. stands at -4.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -2.1%, showing how much profit it generates from its asset base. A current ratio of 22.63 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -169.9%, the inverse of the P/E and a quick read on earnings relative to price.

Company Profile

Nextel Medical Corp. operates in the Healthcare sector. It is headquartered in Saint Petersburg, United States.

MAJI Latest News

No recent news available for MAJI.

MAJI Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MAJI.

Price Targets

Wall Street price target analysis for MAJI.

MAJI MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MAJI; grades run from A+ (80-100) to F (below 30).

Leadership: Donald J. Steinberg

Managing

Donald J. Steinberg currently manages Marijuana Inc., overseeing a small team of two employees. His role involves directing the company's distribution efforts within the cannabis market. Given the company's size, his responsibilities likely encompass a wide range of operational and strategic functions.

Track Record: Due to limited information available, it is difficult to assess Donald J. Steinberg's track record at Marijuana Inc. Key milestones and strategic decisions under his leadership are not publicly documented. The company's recent name change in October 2024 to Marijuana Inc. suggests a strategic shift during his tenure. Further information is needed to evaluate his performance and contributions to the company's growth and development.

MAJI OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Marijuana Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies on the OTC Other tier often have limited trading volume and may not be required to provide audited financial statements. Investing in companies on this tier carries significant risks due to the lack of transparency and regulatory oversight compared to exchanges like the NYSE or NASDAQ. This tier is often populated by shell companies, bankrupt entities, or companies with questionable operations.

  • OTC Tier: OTC Other
Liquidity: Liquidity for Marijuana Inc. is likely very limited due to its OTC Other listing and small market capitalization. This suggests a wide bid-ask spread, making it difficult to buy or sell shares without significantly impacting the price. Low trading volume can also make it challenging to exit a position quickly. Investors should be aware of the potential for price manipulation and illiquidity when trading OTC Other stocks.
OTC Risk Factors:
  • Limited financial disclosure and transparency.
  • High risk of fraud or misrepresentation.
  • Potential for price manipulation due to low trading volume.
  • Illiquidity and difficulty exiting a position.
  • Lack of regulatory oversight and investor protection.
Due Diligence Checklist:
  • Verify the company's legal status and registration.
  • Obtain and review any available financial statements.
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's compliance with relevant regulations.
  • Understand the risks associated with investing in OTC Other stocks.
  • Consult with a qualified financial advisor.
Legitimacy Signals:
  • Company has been in operation since 2010.
  • Company is registered in Florida.
  • Company's name change reflects a strategic focus on the cannabis market.

Nextel Medical Corp. Healthcare Stock: Key Questions Answered

What do analysts say about MAJI stock?

As of 2026-03-16, there is no available analyst coverage or consensus on Marijuana Inc. due to its small market capitalization, OTC listing, and limited financial disclosure. Key valuation metrics such as price targets and earnings estimates are not available.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited information available on Marijuana Inc. due to its OTC listing and small size.
  • Financial data is based on available information and may not be comprehensive.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

Stock Deep Dives